Gambro equipment

About Gambro

Gambro is a Swedish medical technology manufacturer of dialysis and extracorporeal therapy equipment. It was founded in Lund, Sweden in 1964, when industrialist Holger Crafoord partnered with Professor Nils Alwall to commercialize Alwall's artificial kidney invention. The company is headquartered in Lund, Sweden. Its product range covers hemodialysis machines, peritoneal dialysis systems, renal intensive care systems, extracorporeal therapy devices, dialyzers and filters, and blood component technology. Gambro has been part of Baxter International since the acquisition completed on September 6, 2013. On Questpair, the listed Gambro equipment is used, drawn from verified suppliers and distributors.

Gambro dialysis and extracorporeal therapy lines

Gambro's catalogue is organised around the treatment of kidney failure and the handling of blood outside the body. Hemodialysis machines form the core, pairing with dialyzers and filters that carry out the actual separation of waste from blood during a treatment session. These dialyzers do hemodialysis, the extracorporeal process at the centre of renal replacement therapy, and the field is a long-standing one in molecular diagnostics and clinical nephrology where blood chemistry is measured and corrected. Peritoneal dialysis systems take a different route, using the patient's own peritoneal membrane rather than an external filter, and they extend the company's reach from in-centre treatment to home-based therapy.

Renal intensive care systems sit alongside these for critically ill patients, where continuous renal replacement therapy is run at the bedside over extended periods. Gambro's blood component technology connects to the wider field of extracorporeal blood handling, work that overlaps with cell separation and the processing steps used in transfusion medicine and in parts of biomanufacturing. These systems are also used for therapeutic apheresis, the selective removal of blood components. Across the range, the common thread is extracorporeal therapy, the discipline of treating blood and clearing it of waste products while it circulates outside the patient, which is where Gambro concentrated its engineering from the beginning.

For a buyer, the practical value of this lineage is that the equipment classes are purpose-built rather than adapted. A dialyzer, a peritoneal dialysis cycler and a continuous renal replacement unit each address a specific clinical workflow, and the listed devices reflect that specialisation. The vocabulary of the field, hemodialysis, peritoneal dialysis, renal intensive care and extracorporeal therapy, maps directly onto the catalogue categories, so a buyer searching for a particular therapy type will find the equipment grouped the way clinical practice groups it.

What Gambro equipment is listed on Questpair?

The Gambro listings on Questpair are used. Of the catalogue, 100 percent of the listings are used. Prices range from EUR 1.338 to EUR 3.567, with an average of EUR 1.813. The supply is drawn from 2 suppliers across 2 countries, which keeps the pool focused on sellers that handle renal and extracorporeal therapy equipment.

Because the listings are pre-owned, the detail on each one carries the information a buyer needs: the specific model, its condition, and any accessories or consumable interfaces included. Warranty is not applied across the catalogue; where it is available it is arranged in consultation for the specific listing. Parts for listed Gambro equipment can be sourced via Questpair, and documentation or manual requests can be directed to Questpair, where specialists respond within the hour. Questpair lists and connects verified suppliers and distributors, and it does not itself perform repair or servicing, so a buyer intending to return a hemodialysis machine or a renal intensive care system to clinical service should plan commissioning and validation separately.

For a renal unit, a clinical engineering team or a reseller, the catalogue offers a specialist, used supply of dialysis and extracorporeal therapy devices at prices below new. The value lies in sourcing purpose-built renal equipment from a focused maker, with the individual listing as the point where a buyer confirms exactly what a given unit includes.

Questpair review of Gambro

Our take based on listings data and supplier feedback

Gambro occupies a narrow and well-defined position in medical technology: renal replacement therapy and the broader field of extracorporeal treatment. That focus is the first thing worth weighing when assessing the listed equipment. The company did not assemble a dialysis division alongside unrelated product lines. It was founded in 1964 specifically to commercialize Nils Alwall's artificial kidney, and the hemodialysis machines, dialyzers and renal intensive care systems that followed grew directly from that starting point. For a buyer evaluating used renal care equipment, provenance of this kind matters, because the design lineage runs through decades of work on a single clinical problem rather than through a general medical instrument catalogue.

The second consideration is condition and price. Every Gambro listing on Questpair is used, so 100 percent of the listings are used. Prices run from EUR 1.338 to EUR 3.567. The average sits at EUR 1.813. These figures describe a catalogue of pre-owned dialysis and extracorporeal therapy devices rather than a mix of new and reconditioned stock, which sets a clear expectation: a buyer here is sourcing used equipment at prices below new, and the individual listing is where condition, accessories and any arrangements have to be read in detail. Warranty, where it applies, is arranged in consultation for the specific listing rather than offered centrally.

The third point concerns continuity of support for the installed base. Gambro was acquired by Baxter International on September 6, 2013, which places its dialysis technology inside one of the larger medical technology groups. For a buyer, the practical effect is that these are not products from a maker that has disappeared. Parts for listed equipment can be sourced via Questpair, and documentation requests can be directed to Questpair, where specialists respond within the hour. Questpair does not carry out repair or servicing itself, so a buyer planning to put renal intensive care systems or hemodialysis machines back into clinical use will need to factor commissioning and validation into their own planning.

Taken together, the three benefits describe a focused catalogue rather than a broad one. The equipment comes from a specialist whose entire history is renal and extracorporeal therapy, it is listed used at prices below new, and the underlying technology sits within an active parent group. What the catalogue does not offer is new stock or a single standardized condition grade, so the detail on each listing does the work of telling a buyer exactly what a given dialyzer, filter or peritoneal dialysis system includes. For a renal unit, a clinical engineering department or a reseller sourcing extracorporeal therapy devices, that trade of breadth for specialism is the defining characteristic of what is available here. The available supply spans 2 suppliers across 2 countries, which keeps the sourcing pool small and specific rather than fragmented across many sellers.

**Specialist renal therapy focus**

Gambro built its entire product range around dialysis and extracorporeal therapy, so the listed equipment comes from a maker whose hemodialysis machines and dialyzers were its core business rather than a side line.

**Used supply below new pricing**

All listed Gambro units are used, priced from EUR 1.338 to EUR 3.567, which sits below the cost of new renal care equipment.

**Baxter continuity for parts**

Gambro became part of Baxter International in 2013, meaning the installed base of these dialysis systems continues within an active medical technology group.